Factors influencing serum neurofilament light chain levels in normal aging.


Journal

Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617

Informations de publication

Date de publication:
18 12 2021
Historique:
received: 21 07 2021
accepted: 08 12 2021
pubmed: 20 12 2021
medline: 1 2 2022
entrez: 19 12 2021
Statut: ppublish

Résumé

Serum neurofilament light (sNfL) is a promising marker for neuro-axonal damage and it is now well known that its levels also increase with higher age. However, the effect of other determinants besides age is still poorly investigated. We therefore aimed to identify factors influencing the sNfL concentration by analysing a large set of demographical, life-style and clinical variables in a normal aging cohort. sNfL was quantified by single molecule array (Simoa) assay in 327 neurologically inconspicuous individuals (median age 67.8±10.7 years, 192 female) who participated in the Austrian Stroke Prevention Family Study (ASPS-Fam). Random forest regression analysis was used to rank the association of included variables with sNfL in the entire cohort and in age-stratified subgroups. Linear regression then served to identify factors independently influencing sNfL concentration. Age (β=0.513, p<0.001) was by far the most important factor influencing sNfL, which was mainly driven by individuals ≥60 years. In age stratified sub-groups, body mass index (BMI) (β=-0.298, p<0.001) independently predicted sNfL in individuals aged 38-60 years. In individuals ≥60 years, age (β=0.394, p<0.001), renal function (β=0.376, p<0.001), blood volume (β=-0.198, p=0.008) and high density lipoprotein (HDL) (β=0.149, p=0.013) were associated with sNfL levels. Age is the most important factor influencing sNfL concentrations, getting increasingly relevant in elderly people. BMI further influences sNfL levels, especially at younger age, whereas renal function gets increasingly relevant in the elderly.

Identifiants

pubmed: 34923481
pii: 203790
doi: 10.18632/aging.203790
pmc: PMC8751593
doi:

Substances chimiques

Biomarkers 0
Neurofilament Proteins 0
neurofilament protein L 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

25729-25738

Références

J Neurol Sci. 1994 Apr;122(2):189-203
pubmed: 8021703
Clin Chem Lab Med. 2016 Oct 1;54(10):1655-61
pubmed: 27071153
Brain Inj. 2011;25(4):370-8
pubmed: 21355671
Acta Ophthalmol. 2020 May;98(3):e393-e394
pubmed: 31602820
BMC Bioinformatics. 2007 Jan 25;8:25
pubmed: 17254353
Brain. 2020 Jul 1;143(7):1975-1998
pubmed: 32408345
Neurology. 1999 Jul 13;53(1):132-9
pubmed: 10408549
Aging (Albany NY). 2019 Sep 12;11(17):6904-6914
pubmed: 31514172
Diabetes Care. 2010 Dec;33(12):2489-95
pubmed: 20852031
Nat Commun. 2020 Feb 10;11(1):812
pubmed: 32041951
Sci Rep. 2020 Nov 23;10(1):20350
pubmed: 33230211
Neuroepidemiology. 1994;13(6):308-13
pubmed: 7800110
Transl Psychiatry. 2019 Aug 1;9(1):180
pubmed: 31371701
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Nat Rev Neurol. 2018 Oct;14(10):577-589
pubmed: 30171200
Stroke. 2019 Jul;50(7):1669-1675
pubmed: 31138085
J Stroke. 2018 May;20(2):228-238
pubmed: 29886723
Surgery. 1962 Feb;51(2):224-32
pubmed: 21936146
Ann Neurol. 2017 Jun;81(6):857-870
pubmed: 28512753
Ann Clin Transl Neurol. 2020 Jan;7(1):139-143
pubmed: 31893563

Auteurs

Marisa Koini (M)

Clinical Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.

Lukas Pirpamer (L)

Clinical Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.

Edith Hofer (E)

Clinical Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.
Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.

Arabella Buchmann (A)

Department of Neurology, Medical University of Graz, Graz, Austria.

Daniela Pinter (D)

Department of Neurology, Medical University of Graz, Graz, Austria.

Stefan Ropele (S)

Department of Neurology, Medical University of Graz, Graz, Austria.

Christian Enzinger (C)

Department of Neurology, Medical University of Graz, Graz, Austria.
Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz, Graz, Austria.

Pascal Benkert (P)

Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.

David Leppert (D)

Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.

Jens Kuhle (J)

Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.

Reinhold Schmidt (R)

Clinical Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.

Michael Khalil (M)

Department of Neurology, Medical University of Graz, Graz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH